Amalgamated Bank Immuno Gen, Inc. Transaction History

Amalgamated Bank

$12.1 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$12.46 - $29.95 $24,782 - $59,570	-1,989 Reduced 6.4%	29,087 $862,000
Q3 2023 Nov 08, 2023	BUY	$14.09 - $19.87 $9,186 - $12,955	652 Added 2.14%	31,076 $493,000
Q2 2023 Aug 11, 2023	BUY	$3.75 - $20.05 $16,098 - $86,074	4,293 Added 16.43%	30,424 $574,000
Q1 2023 May 02, 2023	SELL	$3.67 - $4.92 $17,399 - $23,325	-4,741 Reduced 15.36%	26,131 $100,000
Q3 2022 Nov 09, 2022	BUY	$4.48 - $6.47 $1,214 - $1,753	271 Added 0.89%	30,872 $148,000
Q2 2022 Aug 15, 2022	BUY	$3.15 - $5.76 $6,895 - $12,608	2,189 Added 7.7%	30,601 $138,000
Q1 2022 Jun 30, 2022	SELL	$4.26 - $7.48 $9,785 - $17,181	-2,297 Reduced 7.48%	28,412 $135,000
Q4 2021 Feb 15, 2022	SELL	$4.75 - $7.5 $1,448 - $2,287	-305 Reduced 0.98%	30,709 $228,000
Q3 2021 Oct 29, 2021	SELL	$5.02 - $6.59 $7,801 - $10,240	-1,554 Reduced 4.77%	31,014 $176,000
Q2 2021 Aug 16, 2021	BUY	$5.79 - $8.6 $70,985 - $105,436	12,260 Added 60.37%	32,568 $215,000
Q1 2021 May 13, 2021	SELL	$6.5 - $10.53 $3,113 - $5,043	-479 Reduced 2.3%	20,308 $164,000
Q4 2020 Feb 12, 2021	BUY	$3.7 - $7.66 $3,267 - $6,763	883 Added 4.44%	20,787 $134,000
Q3 2020 Oct 30, 2020	SELL	$3.45 - $4.89 $997 - $1,413	-289 Reduced 1.43%	19,904 $72,000
Q2 2020 Aug 10, 2020	SELL	$3.32 - $5.34 $13,655 - $21,963	-4,113 Reduced 16.92%	20,193 $93,000
Q1 2020 May 13, 2020	BUY	$2.12 - $6.8 $739 - $2,373	349 Added 1.46%	24,306 $83,000
Q4 2019 Feb 13, 2020	BUY	$2.25 - $5.8 $560 - $1,444	249 Added 1.05%	23,957 $122,000
Q3 2019 Nov 13, 2019	SELL	$2.22 - $3.39 $481 - $735	-217 Reduced 0.91%	23,708 $57,000
Q2 2019 Aug 14, 2019	BUY	$1.8 - $3.3 $2,766 - $5,072	1,537 Added 6.87%	23,925 $52,000
Q1 2019 May 15, 2019	BUY	$2.41 - $5.91 $1,821 - $4,467	756 Added 3.49%	22,388 $61,000
Q4 2018 Feb 15, 2019	BUY	$3.94 - $9.7 $85,230 - $209,830	21,632 New	21,632 $104,000
Q3 2018 Nov 14, 2018	SELL	$8.6 - $11.26 $167,949 - $219,896	-19,529 Closed	0 $0
Q2 2018 Jul 18, 2018	BUY	$9.52 - $12.15 $58,862 - $75,123	6,183 Added 46.33%	19,529 $190,000
Q1 2018 May 22, 2018	SELL	$6.7 - $12.95 $1,340 - $2,590	-200 Reduced 1.48%	13,346 $140,000
Q4 2017 Feb 13, 2018	BUY	$5.07 - $7.92 $14,368 - $22,445	2,834 Added 26.46%	13,546 $87,000
Q3 2017 Nov 09, 2017	BUY	$5.4 - $8.47 $57,844 - $90,730	10,712	10,712 $82,000

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account